- Home
- BPMC vs LNC Comparison
BPMC vs LNC Comparison
Compare BPMC & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- LNC
- Stock Information
- Founded
- BPMC 2008
- LNC 1905
- Country
- BPMC United States
- LNC United States
- Employees
- BPMC N/A
- LNC N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- LNC Life Insurance
- Sector
- BPMC Health Care
- LNC Finance
- Exchange
- BPMC Nasdaq
- LNC Nasdaq
- Market Cap
- BPMC 5.8B
- LNC 5.5B
- IPO Year
- BPMC 2015
- LNC N/A
- Fundamental
- Price
- BPMC $101.35
- LNC $33.14
- Analyst Decision
- BPMC Buy
- LNC Hold
- Analyst Count
- BPMC 18
- LNC 11
- Target Price
- BPMC $125.88
- LNC $36.82
- AVG Volume (30 Days)
- BPMC 789.4K
- LNC 1.8M
- Earning Date
- BPMC 05-01-2025
- LNC 05-08-2025
- Dividend Yield
- BPMC N/A
- LNC 5.43%
- EPS Growth
- BPMC N/A
- LNC N/A
- EPS
- BPMC N/A
- LNC 7.17
- Revenue
- BPMC $562,121,000.00
- LNC $18,544,000,000.00
- Revenue This Year
- BPMC $44.49
- LNC $5.25
- Revenue Next Year
- BPMC $33.04
- LNC $1.94
- P/E Ratio
- BPMC N/A
- LNC $4.62
- Revenue Growth
- BPMC 99.19
- LNC 54.56
- 52 Week Low
- BPMC $73.04
- LNC $27.58
- 52 Week High
- BPMC $121.90
- LNC $39.85
- Technical
- Relative Strength Index (RSI)
- BPMC 56.34
- LNC 49.45
- Support Level
- BPMC $94.38
- LNC $31.61
- Resistance Level
- BPMC $102.52
- LNC $33.59
- Average True Range (ATR)
- BPMC 3.77
- LNC 0.79
- MACD
- BPMC -0.38
- LNC -0.09
- Stochastic Oscillator
- BPMC 79.29
- LNC 37.41
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.